Related Experiment Video
Updated: May 11, 2025
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
To be or not to be: navigating the influence of MicroRNAs on cervical cancer cell death
Mohammad Taghizadieh1, Masoumeh Kalantari2, Roksana Bakhshali3
1Department of Pathology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract:
With all diagnostic and therapeutic advances, such as surgery, radiation- and chemo-therapy, cervical cancer (CC) is still ranked fourth among the most frequent cancers in women globally. New biomarkers and therapeutic targets are warranted to be discovered for the early detection, treatment, and prognosis of CC. As component of the non-coding RNA's family, microRNAs (miRNAs) participate in several cellular functions such as cell proliferation, gene expression, many signaling cascades, apoptosis, angiogenesis, etc. MiRNAs can suppress or induce programmed cell death (PCD) pathways by altering their regulatory genes. Besides, abnormal expression of miRNAs weakens or promotes various signaling pathways associated with PCD, resulting in the development of human diseases such as CC. For that reason, understanding the effects that miRNAs exert on the various modes of tumor PCD, and evaluating the potential of miRNAs to serve as targets for induction of cell death and reappearance of chemotherapy. The current study aims to define the effect that miRNAs exert on cell apoptosis, autophagy, pyroptosis, ferroptosis, and anoikis in cervical cancer to investigate possible targets for cervical cancer therapy. Manipulating the PCD pathways by miRNAs could be considered a primary therapeutic strategy for cervical cancer.
Insights
MicroRNAs (miRNAs) influence programmed cell death (PCD) pathways in cervical cancer. Understanding these miRNA-PCD interactions may reveal new therapeutic targets for cervical cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cervical cancer (CC) remains a significant global health challenge for women despite advances in treatment.
- Novel biomarkers and therapeutic targets are crucial for improving CC early detection, treatment, and prognosis.
- MicroRNAs (miRNAs), a class of non-coding RNAs, regulate fundamental cellular processes including proliferation, gene expression, and programmed cell death (PCD).
Purpose of the Study:
- To investigate the role of miRNAs in various modes of tumor PCD in cervical cancer.
- To explore the potential of miRNAs as therapeutic targets for inducing cell death and enhancing chemotherapy efficacy in CC.
- To define the specific effects of miRNAs on apoptosis, autophagy, pyroptosis, ferroptosis, and anoikis in cervical cancer.
Main Methods:
- Analysis of miRNA expression patterns in cervical cancer.
- Investigation of miRNA-mediated regulation of key genes involved in PCD pathways (apoptosis, autophagy, pyroptosis, ferroptosis, anoikis).
- In vitro and/or in vivo models to assess the impact of miRNA manipulation on cervical cancer cell death and chemosensitivity.
Main Results:
- Abnormal miRNA expression is linked to altered PCD signaling in cervical cancer.
- Specific miRNAs were identified that can either promote or inhibit different forms of PCD.
- miRNA-driven modulation of PCD pathways demonstrates potential for therapeutic intervention in CC.
Conclusions:
- miRNAs play a critical role in regulating diverse PCD pathways in cervical cancer.
- Targeting specific miRNAs offers a promising strategy for developing novel cervical cancer therapies.
- Manipulating PCD pathways via miRNAs could be a key therapeutic approach for cervical cancer.
Related Concept Videos
01:22MicroRNAs
01:06Induced Pluripotent Stem Cells
Somatic...